DBX4:F:F-Xtrackers - MSCI EM Europe Middle East & Africa Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 34.23

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.66 (-1.27%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.34 (-0.24%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.69 (-1.20%)

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.19 (-1.20%)

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.80 (-1.20%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-0.20 (-0.20%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.05 (-0.63%)

USD 46.87B
0ZC:F Zscaler Inc

-0.05 (-0.02%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.37%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing DBX4:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.57% 72% C 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.57% 72% C 63% D
Trailing 12 Months  
Capital Gain 22.42% 91% A- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.42% 88% B+ 71% C-
Trailing 5 Years  
Capital Gain 61.16% 63% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.16% 63% D 48% F
Average Annual (5 Year Horizon)  
Capital Gain 7.44% 61% D- 60% D-
Dividend Return 7.44% 58% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.14% 59% D- 89% A-
Risk Adjusted Return 66.81% 68% D+ 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike